Got $1,000? 2 No-Brainer Nuclear Stocks to Buy Right Now.

Key Points Oklo is developing advanced nuclear reactors but remains pre-revenue, posting a $124.2 million operating loss in early 2026. Cameco already generates steady revenue from uranium production, fuel services, and its 49% stake in Westinghouse. Analysts rate Oklo a "moderate buy" with higher upside potential, while Cameco rates a "strong buy" with more modest gains. 10 stocks we like better than Oklo › With $1,000 to invest, these two nuclear stocks look like straightforward buys today, with each company offering a different yet compelling way to capitalize on growing energy demand.